References
- Pacini F, Schlumberger M, Dralle H, Elisei R, Smith JW, Wiersinga W. The European Thyroid Cancer Taskforce. European concensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787-803.
- Schlumberger M, Charbord P, Fragu P, Lumbroso J, Parmentier C Tubiana M. Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels. J Clin Endocrinol Metab 1980; 51: 513-9.
- Ladenson PW, Bravermann LE, Mazzaferi ME, Brucker-Davis F. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroide hormone for radioactive scanning in patients with thyroid cancer. N Engl J Med 1997; 337: 888-96.
- Park JT, Hennessey JV. Two-week low iodine diet is necessary for adequate outpatient preparation for radioiodine rhTSH scanning in patients taking levothyroxine. Thyroid 2004; 14: 57-63.
- Pluijmen M, Eustatia-Rutten C, Goslings BM, Stokkel MP, Pereira Arias AM, Diamant M, et al. Effects of low-iodide diet on post surgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma. Clin Endocrinol 2003; 58: 428-35.
- Tomoda C, Uruno T, Takamura Y, Ito Y, Miya A, Kobayashi K, et al. Reevaluation of stringent low iodine diet in outpatient preparation of radioiodine examination and therapy. Endocr J 2005; 52: 237-40.
- WHO, UNICEF, ICCIDD. Assessment of the Iodine Deficiency Disorders and Monitoring Their Elimination. World Health Organisation, 2001. WHO Document WHO/NHD/01.1
- Schlumberger M, Mancusi F, Baudin E, Pacini F. 131I therapy for elevated thyroglobulin levels. Thyroid 1997; 7: 273-6.
- Chao M. Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan. Clin Oncol (R Coll Radiol) 2010; 22: 438-47.
- Benotti J, Benotti N, Pino S, Gardyna H. Determination of total iodine in urine, stool, diets and tissue. Clinical Chem 1965; 11: 932-6.
- Yates J S, Thomas H C. Kinetics of the iodide-catalyzed reaction betwen cerium (IV) and arsenic (III). JACS 1956; 78: 3950-3.
- Jooste PL, Strydom E. Methods for determination of iodine in urine and salt. Best Pract Res Clin Endocrinol Metab 2010; 24: 77-88.
- The Instructions for Table Salt Iodinesation. The Official Gazette No 8, 09.10.1996.
- Chung JK, Lee YJ, Jeong JM, Lee DS, Lee MC, Cho BY, et al. Clinical significance of hepatic visualization on iodine-131 whole-body scan in patients with thyroid carcinoma. J Nucl Med 1997; 38: 1191-5.
- Tatar FA, Morita E, Ituarte PH, Cavalieri RR, Duh QY, Price DC, et al. Association between residual thyroid carcinoma and diffuse hepatic uptake of 131I following radioiodine ablation in postoperative total thyroidectomy patients. World J Surg 2001; 25: 718-22.
- Omür O, Akgün A, Ozcan Z, Sen C, Ozkiliç H. Clinical implications of diffuse hepatic uptake observed in postablative and post-therapeutic I-131 scans. Clin Nucl Med 2009; 34: 11-4.
- Mowlavi AA, Fornasier MR, de Denaro M. Thyroid volume's influence on energy deposition from 131I calculated by Monte Carlo (MC) simulation. Radiol Oncol 2011; 45(2): 143-6.
- Morris LF, Wilder MS, Waxmann AD, Braunstein Gd. Reevaluation of the impact of a stringent low-iodine diet on ablation rates in radioiodine treatment of thyroid carcinoma. Thyroid 2001; 11: 749-55.
- Ma C, Kuang A, Xie J, Ma T. Possible Explanations for Patients with Discordant Findings of Serum Thyroglobulin and 131I Whole-Body Scanning. J Nucl Med 2005; 46: 1473-1480.